insights_auto
Why is TNDM up ၂.၁၁%?
Dive Deeperchevron_right
TNDM:NASDAQ
Tandem Diabetes Care Inc
၁၆.၄၅ US$
arrow_upward
+၂.၁၁%(+၀.၃၄) 1D
၁၆.၄၅ US$
၀.၀၀% (၀.၀၀)
bedtimeAfter hours
Closed: အောက် ၁၂, GMT-၄ ၁၆:၀၀:၀၁ · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TNDM...
Open
၁၆.၁၁ US$
High
၁၆.၉၁ US$
Low
၁၅.၈၆ US$
Mkt. cap
၁၁၄.၄၆ ဋေ
Avg. vol.
၂.၀၅ သန်း
Volume
၁.၅၈ သန်း
52-wk high
၂၉.၆၅ US$
52-wk low
၁၂.၂၆ US$
EPS
-၀.၉၃ US$
Beta
၁.၆၆
Shares outstanding
၆.၉၆ ကုဋေ
No. of employees
၂ ထောင်
Open
၁၆.၁၁ US$
High
၁၆.၉၁ US$
Low
၁၅.၈၆ US$
Mkt. cap
၁၁၄.၄၆ ဋေ
Avg. vol.
၂.၀၅ သန်း
Volume
၁.၅၈ သန်း
52-wk high
၂၉.၆၅ US$
52-wk low
၁၂.၂၆ US$
EPS
-၀.၉၃ US$
Beta
၁.၆၆
Shares outstanding
၆.၉၆ ကုဋေ
No. of employees
၂ ထောင်
News stories
From web sources and news partners
Benzinga
·
ပြီးခဲ့သည့် ၁၂ နာရီ
Tandem Diabetes Care Q2 2026 Earnings Call Transcript
Profile
Tandem Diabetes Care, Inc. is an American medical-device company that develops and markets insulin pumps, automated insulin delivery systems and diabetes-management software. Headquartered in San Diego, California, its principal pump platforms are the t:slim X2 and Tandem Mobi, both of which use the company's Control-IQ+ software with compatible continuous glucose monitors.
Tandem was founded in 2006 and introduced its first pump, the touchscreen t:slim, in 2012. The company became publicly traded on the Nasdaq in 2013. By the end of 2025 it reported an in-warranty user base of nearly 500,000 people in more than 25 countries and annual sales of $1.015 billion. Wikipedia
About Tandem Diabetes Care Inc